av/armata-pharmaceuticals--big.svg

AMEX:ARMP

Armata Pharmaceuticals, Inc.

  • Stock

USD

Last Close

2.21

25/09 13:50

Market Cap

96.89M

Beta: 0.54

Volume Today

450

Avg: 13.05K

PE Ratio

−2.27

PFCF: −2.59

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
325K
-
409K
25.85%
475K
16.14%
260K
45.26%
115K
55.77%
823K
-
4.47M
443.62%
5.51M
23.11%
4.53M
17.77%
cost of revenue
1.35M
-
14.44M
969.13%
20.02M
38.57%
892K
95.54%
972K
8.97%
gross profit
325K
-
409K
25.85%
475K
16.14%
260K
45.26%
115K
55.77%
-1.35M
-
-13.62M
908.22%
-15.54M
14.10%
4.62M
129.70%
3.56M
22.94%
selling and marketing expenses
1.86M
-
289K
84.50%
-972K
-
general and administrative expenses
8.81M
-
6.85M
22.24%
6.42M
6.26%
8.41M
31.02%
7.59M
9.78%
5.70M
24.87%
9.27M
62.49%
7.97M
14.02%
8.28M
3.95%
7.44M
10.19%
11.65M
56.64%
selling general and administrative expenses
8.81M
-
8.71M
1.08%
6.71M
23.00%
8.41M
25.38%
7.59M
9.78%
5.70M
24.87%
9.27M
62.49%
7.97M
14.02%
8.28M
3.95%
7.44M
10.19%
10.68M
43.57%
research and development expenses
6.50M
-
5.80M
10.72%
3.99M
31.23%
5.68M
42.23%
2.88M
49.26%
4.89M
69.80%
9.82M
100.82%
14.44M
47.03%
20.02M
38.57%
35.02M
74.95%
33.77M
3.56%
other expenses
1.86M
-
-302K
116.20%
-554K
83.44%
6K
101.08%
1.93M
32,066.67%
-844K
143.73%
-823K
2.49%
-4.47M
443.62%
-5.51M
23.11%
cost and expenses
15.31M
-
14.52M
5.17%
10.70M
26.29%
14.09M
31.67%
10.47M
25.69%
10.59M
1.17%
19.09M
80.19%
21.59M
13.09%
23.82M
10.35%
36.95M
55.09%
45.42M
22.93%
operating expenses
15.31M
-
14.52M
5.17%
10.70M
26.29%
14.09M
31.67%
10.47M
25.69%
10.59M
1.17%
19.09M
80.19%
21.59M
13.09%
23.82M
10.35%
36.95M
55.09%
44.45M
20.30%
interest expense
2.86M
-
931K
-
628K
32.55%
64K
89.81%
29K
54.69%
2.63M
8,955.17%
ebitda
25.66M
-
-51.17M
299.43%
-19.54M
61.82%
-8.45M
56.73%
-6.20M
26.68%
-8.36M
34.90%
-18.19M
117.58%
-20.44M
12.35%
-22.65M
10.81%
-36.05M
59.19%
-39.92M
10.72%
operating income
-14.99M
-
-14.11M
5.85%
-10.23M
27.52%
-23.38M
128.59%
-16.16M
30.89%
-12.52M
22.48%
-19.75M
57.71%
-21.59M
9.29%
-23.82M
10.35%
-36.95M
55.09%
-40.89M
10.68%
depreciation and amortization
82K
-
158K
92.68%
330K
108.86%
369K
11.82%
374K
1.36%
389K
4.01%
1.56M
301.03%
1.15M
26.41%
1.17M
2.26%
892K
24.02%
972K
8.97%
total other income expenses net
-40.56M
-
37.22M
191.76%
9.64M
74.10%
-5.56M
157.72%
-3.78M
31.98%
-1.84M
51.27%
273K
114.80%
-594K
317.58%
667K
212.29%
29K
95.65%
-28.16M
97,186.21%
income before tax
-58.41M
-
23.11M
139.56%
-589K
102.55%
-19.39M
3,192.70%
-14.14M
27.09%
-12.44M
12.04%
-19.48M
56.61%
-22.18M
13.87%
-23.16M
4.39%
-36.92M
59.43%
-69.05M
87.03%
income tax expense
43.42M
-
-37.22M
185.71%
-73K
99.80%
-556K
661.64%
-1.30M
134.17%
-328K
74.81%
-454K
38.41%
634K
239.65%
64K
89.91%
-29K
145.31%
net income
-58.41M
-
23.11M
139.56%
-516K
102.23%
-18.84M
3,550.78%
-12.84M
31.85%
-12.11M
5.67%
-19.02M
57.10%
-22.82M
19.92%
-23.22M
1.77%
-36.89M
58.87%
-69.05M
87.17%
weighted average shs out
14.46K
-
26.76K
85.11%
38.65K
44.43%
70.28K
81.82%
456.25K
549.23%
1.36M
198.40%
7.83M
474.93%
16.42M
109.72%
24.10M
46.84%
34.29M
42.27%
36.08M
5.19%
weighted average shs out dil
14.46K
-
42.05K
190.85%
38.65K
8.08%
70.28K
81.82%
469.58K
568.21%
1.36M
189.92%
7.83M
474.93%
16.42M
109.72%
24.10M
46.84%
34.29M
42.27%
36.08M
5.19%
eps
-4.04K
-
589.40
114.59%
-13.35
102.27%
-268.06
1,907.94%
-28.14
89.50%
-8.90
68.37%
-2.43
72.70%
-1.39
42.80%
-0.96
30.94%
-1.08
12.50%
-1.91
76.85%
epsdiluted
-4.04K
-
-326.20
91.93%
-13.35
95.91%
-268.06
1,907.94%
-27.34
89.80%
-8.90
67.45%
-2.43
72.70%
-1.39
42.80%
-0.96
30.94%
-1.08
12.50%
-1.91
76.85%

All numbers in USD (except ratios and percentages)